Epcoritamab (TEPKINLY®) Gains CHMP Approval for Follicular Lymphoma
Genmab A/S (Nasdaq: GMAB) announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting conditional marketing authorization for epcoritamab (TEPKINLY®). This…
Pulse Biosciences Announces Preliminary Results of Rights Offering
Pulse Biosciences, Inc. (Nasdaq: PLSE), leveraging its CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, disclosed today the preliminary outcomes of its recently concluded rights offering. The offering, which expired at…
Tebra Launches Enhanced Products for More Patient Time
Tebra, the comprehensive platform for independent healthcare providers, has announced multiple new product enhancements in the second quarter aimed at maximizing time spent with patients. This announcement coincides with the…
CDC Recommends Merck’s CAPVAXIVE™ for Adult Pneumococcal Vaccination
Merck (NYSE: MRK), also known as MSD outside of the United States and Canada, announced today that the U.S. Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization…
ObjectiveHealth, QualDerm Expand Partnership to Enhance Patient Care Options
ObjectiveHealth, a Nashville-based integrated research and technology platform company, has announced an expansion of its partnership with QualDerm Partners, LLC, a leading dermatology and skin care management services organization also…
Genoks and Velsera Partner to Transform Cancer Diagnostics in Turkey
Genoks, a leading genomics healthcare company based in Turkey, has partnered with Velsera, a global healthcare technology firm specializing in a universal software platform connecting clinical care with discovery. Together,…
Brenus Pharma Earns Global Cancer Stream Accreditation 2023/2024 from Creative Destruction Lab & NA Universities
Last year, Brenus Pharma was chosen to join CDL Cancer, a global mentoring program supporting highly scalable, science-driven companies advancing cancer treatments. Distinguished by its innovative STC platform focused on…
Augustine Therapeutics Secures EUR 17M for Clinical Development in Neurological Diseases
Augustine Therapeutics, a pioneering biotech firm dedicated to innovative therapies for neurodegenerative and cardiometabolic diseases, has successfully secured EUR 17 million (USD 18.5 million) in the initial closing of its…
ARC Fertility Wins Spring 2024 Digital Health Award for Mobile App
“This award is a testament to our team’s dedication and innovation in developing the FertilityNow app, which offers personalized, convenient, and effective support to make fertility care more accessible and…
PQE Group Launches AI & Data Analytics Division for Life Sciences
PQE Group, a leading consultancy in the Life Science sector, has launched its new Regulated Artificial Intelligence & Data Analytics division, marking a significant advancement since the introduction of AI-based…
Swift Medical Appoints New CEO and CTO to Leadership Team
Swift Medical, a leading digital health technology company specializing in enhancing clinical outcomes in chronic and acute wound care, is pleased to announce the appointment of Dwayne Sansone as Chief…
Greenspace Health Partners Teams Up with Behavioral Health Innovations for Digital Assessments
Greenspace Health and Behavioral Health Innovations (BHI) have announced a strategic partnership aimed at enhancing access to BHI’s evidence-based assessments through digital platforms. This collaboration seeks to streamline the administration…